NxThera ’s Rezūm Provides a New Treatment Option for Patients with BPH: Interview with CEO of NxThera
Benign prostatic hyperplasia (BPH), or enlargement of the prostate gland, affects about half of men between the age of 51 and 60 and up to 90% of men over the age of 80. Symptoms include difficulty with initiating urination, weak urine flow, post-voi...
Source: Medgadget - Category: Medical Equipment Authors: Kenan Raddawi Tags: Exclusive Urology Source Type: blogs
More News: Anatomy | Anesthesia | Anesthesiology | Anxiety | Back Pain | Benign Prostatic Hyperplasia | Beta-Blockers | Bladder Cancer | Bleeding | Cancer | Cancer & Oncology | Cardiology | Chronic Pain | Clinical Trials | Erectile Dysfunction | Health Insurance | Health Management | Heart | High Intensity Focused Ultrasound Therapy | Hospitals | Hypertension | Incontinence | Insurance | Insurers | Learning | Medical Devices | Medicare | Pain | Prostate Cancer | Study | Technology Consultants | Training | Ultrasound | Universities & Medical Training | Urinary Tract Infections | Urology & Nephrology